Epilepsy

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Breastfed children of women on AED therapy showed significantly higher verbal abilities at age 6 years compared to nonbreastfed children, with an adjusted verbal index 4 points higher.

Effect: improvement; adjusted verbal index 4 points higher for breastfed children; CI: 95% CI, 0 to 7

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs

Fetal valproate exposure was associated with lower IQ at age 6 years compared to other AEDs, with adjusted IQ 7-13 points worse, in a dose-dependent manner.

Effect: adverse; adjusted IQ worse by 7-13 IQ points for valproate compared to other drugs